Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells

Although farnesyltransferase inhibitors have shown promising activity in relapsed lymphoma and sporadic activity in acute myelogenous leukemia, their mechanism of cytotoxicity is incompletely understood, making development of predictive biomarkers difficult. In the present study, we examined the act...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ding, Husheng, McDonald, Jennifer S., Yun, Seongseok, Schneider, Paula A., Peterson, Kevin L., Flatten, Karen S., Loegering, David A., Oberg, Ann L., Riska, Shaun M., Huang, Shengbing, Sinicrope, Frank A., Adjei, Alex A., Karp, Judith E., Meng, X. Wei, Kaufmann, Scott H.
Formato: Artigo
Idioma:Inglês
Publicado: Ferrata Storti Foundation 2014
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4007940/
https://ncbi.nlm.nih.gov/pubmed/23996484
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2013.087734
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares